跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BYLVAY 600 MICROGRAMOS CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BYLVAY 600 MICROGRAMOS CAPSULAS DURAS
Approved
STANDARD
BYLVAY 600 MICROGRAMOS CAPSULAS DURAS
Ipsen Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 21, 2021
Approval ID
ee7977a08a0af340
Company
Ipsen Pharma
Type
Standard
Approval Details
Approval Id
ee7977a08a0af340
Drug Cima Aemps Name
BYLVAY 600 MICROGRAMOS CAPSULAS DURAS
Register Number
1211566003
Holder Company Name
Ipsen Pharma
Marketing Company Name
Ipsen Pharma S.A.
Holder Company Detail Path
/organization/ipsen-pharma
Authorization Date
2021-12-21
Dosage Form
CÁPSULA DURA
Dose
600 µg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Ipsen Pharma
Company Detail Path
/organization/ipsen-pharma
Company Information
Pharmaceutical Company Name
IPSEN PHARMA
Country Name
France
City Name
boulogne-billancourt,ile de france,country_fr
Address
65 QUAI GEORGES GORSE
Active Ingredients
ODEVIXIBAT SESQUIHIDRATO
0,622 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 21, 2021
Approval ID
ee7977a08a0af340
Type
Standard
Back to CIMA-AEMPS Approvals